C Liedtke

1.7k citations
47 papers · 1.0k · 1 hit paper · h-index 10

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis
    • Cancer Treatment and Pharmacology
    • Cancer-related Molecular Pathways

Papers in

    • Breast Cancer Treatment Studies 35
    • Cancer Genomics and Diagnostics 7
    • HER2/EGFR in Cancer Research 11
    • Cancer Treatment and Pharmacology 10

C Liedtke

42 papers receiving 977 citations

C Liedtke's Hit Papers

Triple-negative breast cancer—current status and future directions 2009 · 532 citations
5320+5+11Years since publication100200300400500

Peers

C Liedtke
Comparison fields: 5 of 68
  • Cancer Research 457
  • Oncology 431
  • Pulmonary and Respiratory Medicine 155
  • Molecular Biology 267
  • Pathology and Forensic Medicine 57
Replace Ángel Guerrero‐Zotano with:
Ángel Guerrero‐Zotano Spain
Margarita Viladot Spain
Marc Díez Spain
Nina Gottschalk Germany
Daniele Andreis Italy
Joëlle Collignon Belgium
Ali Sak Germany
Yuxi Zhu China
Martina S.J. McDermott United States
Jean Helmijr Netherlands
C Liedtke relative to Ángel Guerrero‐Zotano Spain Ángel Guerrero‐Zotano's profile →
Citations per field
00.5×10×13×
Ángel Guerrero‐Zotano · 1×
Citations per year

Countries citing papers authored by C Liedtke

Since Specialization
Citations

This map shows the geographic impact of C Liedtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Liedtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Liedtke more than expected).

Fields of papers citing papers by C Liedtke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Liedtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Liedtke. The network helps show where C Liedtke may publish in the future.

Co-authors

The 25 scholars most cited alongside C Liedtke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C Liedtke Line = papers co-authored together C Liedtke links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Triple-negative breast cancer—current status and future directions
Hit paper breakdown →
2009532
2 2009232
3 200850
4 201618
5 201215
6 201214
7 200814
8 201611
9 201111
10 201810
11 20089
12 20128
13 20087
14 20106
15 20105
16
Prospective WSG phase III PlanB trial: Clinical outcome at 5 year follow up and impact of 21 Gene Recurrence Score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2-high risk node-negative and -positive breast cancer
20165
17 20185
18 20164
19 20074
20 20084

About C Liedtke

C Liedtke is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 47 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (35 papers), Advanced Breast Cancer Therapies (13 papers), HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (10 papers), Estrogen and related hormone effects (8 papers), Cancer Genomics and Diagnostics (7 papers), BRCA gene mutations in cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Cancer Research (457 citations), Oncology (431 citations), Pulmonary and Respiratory Medicine (155 citations), Molecular Biology (267 citations) and Pathology and Forensic Medicine (57 citations). C Liedtke has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Lajos Pusztai, Oleg Gluz, Ulrike Nitz, Nadia Harbeck, Nina Gottschalk, Ludwig Kiesel, W. Fraser Symmans, Ana M. González-Angulo, Constance T. Albarracin and Richard L. Theriault. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact